Minnesota HF 3919: Prescription drug price transparency act amended, and wholesale drug distributors required to provide information by month in the annual report.

Status: Introduction and first reading, referred to Commerce Finance and Policy (as of 2024-02-19)

State: Minnesota · Session: 2023-2024 · Bill: HF 3919

Subjects: Drugs and Medicine, Health and Health Department

Sponsors: Hemmingsen-Jaeger

View Minnesota HF 3919 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.